Literature DB >> 20584347

Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms.

Susumu Yonesaka1, Toru Takahashi, Shuji Eto, Takumi Sato, Katuki Otani, Tomomi Ueda, Akira Sato, Yosuke Kitagawa, Yuki Konno, Manabu Kinjo.   

Abstract

BACKGROUND: Although most Kawasaki disease with giant coronary aneurysms is asymptomatic, conventional investigations might not identify previous lesions, or all Kawasaki disease with giant aneurysms at risk of future myocardial lesions. We evaluated the long-term histopathology of the myocardium, especially of intramural small vessels in asymptomatic Kawasaki disease with giant aneurysms.
METHOD: The initial study comprised 16 consecutive Kawasaki patients - male-to-female ratio was 12:4 - aged from 2 to 12 years, and in the subsequent study, the same patients were aged from 4.9 to 16 years. Endomyocardial biopsies were histopathologically evaluated. Microangiopathies, mitochondrial abnormalities, and loss or disarray of myofibrils were compared by electron microscopy.
RESULTS: The incidence of histopathological abnormalities such as degeneration, hypertrophy, and inflammatory cell infiltration was quite high in the initial study, and inflammatory cell infiltration, interstitial fibrosis, and disarray were very noticeable at follow-up biopsies. The area of fibrous tissue was significantly higher in patients administered with intravenous immunoglobulin at follow-up biopsies. Electron microscopy showed microangiopathies including microthrombi within intramural small vessels in some patients at follow-up biopsies. The sites of the coronary aneurysms did not seem to have an impact on the biopsy findings, suggesting that the underlying pathophysiology is related to the original disease process.
CONCLUSIONS: Whether the abnormalities were due to direct myocardial injury, chronic ischaemia, repeated small-vessel thrombosis, or other problems associated only with biopsies, is difficult to determine. However, this subgroup had residual abnormal lesions in the myocardium. Follow-up should be more aggressive in this group of patients to identify myocardial damage that could be asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584347     DOI: 10.1017/S1047951109991132

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  12 in total

1.  Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease.

Authors:  Hugo Gravel; Nagib Dahdah; Anne Fournier; Marie-Ève Mathieu; Daniel Curnier
Journal:  Pediatr Cardiol       Date:  2012-02-18       Impact factor: 1.655

2.  Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood.

Authors:  Chisato Shimizu; Alka Sood; Hubert D Lau; Toshiaki Oharaseki; Kei Takahashi; Henry F Krous; Steven Campman; Jane C Burns
Journal:  Cardiovasc Pathol       Date:  2015-02-24       Impact factor: 2.185

3.  Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis.

Authors:  Harry H Matundan; Jon Sin; Magali Noval Rivas; Michael C Fishbein; Thomas J Lehman; Shuang Chen; Roberta A Gottlieb; Timothy R Crother; Masanori Abe; Moshe Arditi
Journal:  JCI Insight       Date:  2019-02-07

4.  Atrioventricular depolarization differences identify coronary artery anomalies in Kawasaki disease.

Authors:  Daniel Cortez; Nandita Sharma; Pei-Ni Jone
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-09-28       Impact factor: 1.468

5.  Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease.

Authors:  Lijian Xie; Renjian Wang; Min Huang; Yongwei Zhang; Jie Shen; Tingting Xiao
Journal:  Cardiovasc Ultrasound       Date:  2016-01-12       Impact factor: 2.062

6.  Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence.

Authors:  Konstantinos Bratis; Pauline Hachmann; Nicholas Child; Thomas Krasemann; Tarique Hussain; Sophie Mavrogeni; Rene Botnar; Reza Razavi; Gerald Greil
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr

7.  Long Term Outcomes of Left Atrial Reservoir Function in Children with a History of Kawasaki Disease.

Authors:  Soo Jung Kang; Jihyun Ha; Seo Jung Hwang; Hyo Jin Kim
Journal:  J Cardiovasc Ultrasound       Date:  2018-03-28

Review 8.  How Should We Classify Kawasaki Disease?

Authors:  Edoardo Marrani; Jane C Burns; Rolando Cimaz
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

9.  Myocardial fibrosis in patients with a history of Kawasaki disease.

Authors:  Susan M Dusenbery; Jane W Newburger; Steven D Colan; Kimberlee Gauvreau; Annette Baker; Andrew J Powell
Journal:  Int J Cardiol Heart Vasc       Date:  2021-01-18

10.  Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction.

Authors:  Shinsuke Hoshino; Chisato Shimizu; Sonia Jain; Feng He; Adriana H Tremoulet; Jane C Burns
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.